Shuwei Gao, M.D.
Department of General Internal Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Internist, Department of General Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1986 | Peking Union Medical College, Beijing, CN, Master of Medicine in Cardiology, M.S |
| 1983 | Beijing Medical University, Beijing, US, MD |
Postgraduate Training
| 2005-2006 | Clinical Safety & Effectiveness Program, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 1995-1998 | Intern/ Resident, University of Texas Medical School at Houston, Houston, Texas |
| 1987-1989 | Postdoctoral Fellow, University of California San Francisco Medical School, San Francisco, California |
Licenses & Certifications
| 2022 | Texas Medical Board |
| 1998 | American Board of Internal Medicine |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Department of General Internal Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX, 1998 - 2007
Research Associate, Department of Biology, City of Hope Medical Center, Duarte, CA, 1989 - 1995
Attending Physician, Cardiovascular Institute and Fuwai Hospital, PUMC, Beijing, 1986 - 1987
Administrative Appointments/Responsibilities
Clinical Director, Coumadin Clinic, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - Present
Other Professional Positions
Program Coordinator, General Internal Medicine Journal Club, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - Present
Extramural Institutional Committee Activities
Member, Clinical Effectiveness Committee, The University of Texas MD Anderson Cancer Center, 2007 - Present
Member, Credential Committee of Medical Staff, The University of Texas MD Anderson Cancer Center, 2003 - Present
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2001 - 2004
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2007. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
- 2006. Hypersensitivity Reactions and Anaphylaxis. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
- 2006. Hypersensitivity Reactions and Anaphylaxis. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
- 2005. Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A comparison with Recommended Sampling Practice. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
- 2003. Oncologic Emergencies. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
- 2001. The Impact of the Introduction of a Rapid D-Dimer Assay on the Diagnostic Evaluation of Suspected Pulmonary Embolism. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
- 2001. D-Dimer Testing for Venous Thromboembolism. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
National Presentations
- 2002. Oncologic Emergencies. Invited. American Radiological Nurses Association (ARNA) 21st Annual Convention. Houston, TX, US.
Selected Publications
Peer-Reviewed Articles
- Streiff MB, Holmstrom B, Angelini D, Ashrani A, Elshoury A, Fanikos J, Fertrin KY, Fogerty AE, Gao S, Goldhaber SZ, Gundabolu K, Ibrahim I, Kraut E, Leavitt AD, Lee A, Lee JT, Lim M, Mann J, Martin K, McMahon B, Moriarty J, Morton C, Ortel TL, Paschal R, Schaefer J, Shattil S, Siddiqi T, Sudheendra D, Williams E, Hollinger L, Nguyen MQ. Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(10):1181-1201, 2021. e-Pub 2021. PMID: 34666313.
- Streiff MB, Holmstrom B, Angelini D, Ashrani A, Bockenstedt PL, Chesney C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Gundabolu K, Hendrie P, Lee AI, Lee JT, Mann J, McMahon B, Millenson MM, Morton C, Ortel TL, Ozair S, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Williams E, Zakarija A, Hammond L, Dwyer MA, Engh AM. NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. J Natl Compr Canc Netw 16(11):1289-1303, 2018. e-Pub 2018. PMID: 30442731.
- Escalante CP, Gladish GW, Qiao W, Zalpour A, Assylbekova B, Gao S, Olejeme KA, Richardson MN, Suarez-Almazor ME. Prospective cohort study of cancer patients diagnosed with incidental venous thromboembolism on routine computed tomography scans. Support Care Cancer 25(5):1571-1577, 2017. e-Pub 2017. PMID: 28070669.
- Zalpour A, Song J, Richardson MN, Lam T, Halm J, Yusuf S, Gao S. Practice patterns and outcomes of rivaroxaban usage in patients with cancer. J Clin Oncol 34(26_suppl):194, 2016. e-Pub 2016. PMID: 28156447.
- Streiff MB, Holmstrom B, Ashrani A, Bockenstedt PL, Chesney C, Eby C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Hendrie P, Kuderer N, Lee A, Lee JT, Lovrincevic M, Millenson MM, Neff AT, Ortel TL, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Yee GC, Zakarija A, McMillian N, Engh AM. Cancer-Associated Venous Thromboembolic Disease, Version 1.2015. J Natl Compr Canc Netw 13(9):1079-95, 2015. e-Pub 2015. PMID: 26358792.
- Gao, S, Caraway N. Fever, Leukocytosis, and Splenomegaly. Primary Care & Cancer 20((9)):39045, 2000. e-Pub 2000.
- Gao S, Drouin R, Holmquist GP. DNA repair rates mapped along the human PGK1 gene at nucleotide resolution. Science 263(5152):1438-40, 1994. e-Pub 1994. PMID: 8128226.
- Gao SW, Morser J, McLean K, Shuman MA. Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase. Thromb Res 58(4):421-33, 1990. e-Pub 1990. PMID: 2112791.
- Gao SW, Chen ZJ, Tao SQ. Effects of low-dose aspirin on platelet aggregation and the biosynthesis of PGI2 and TXA2 in patients with coronary heart disease. Zhonghua Nei Ke Za Zhi 26(4):209-12, 255, 1987. e-Pub 1987. PMID: 3308356.
Review Articles
- Gao S, Escalante C. Venous thromboembolism and malignancy. Expert Rev Anticancer Ther 4(2):303-20, 2004. e-Pub 2004. PMID: 15056060.
- Holmquist GP, Gao S. Somatic mutation theory, DNA repair rates, and the molecular epidemiology of p53 mutations. Mutat Res 386(1):69-101, 1997. e-Pub 1997. PMID: 9100856.
Abstracts
- Escalante CP, Zalpour A, Song J, Richardson M, Halm J, Yusuf SW, Gao S. Adverse events of rivaroxaban usage in cancer patients. Thrombosis Research 164(S1):S220-221, 2018. e-Pub 2018.
- Grover TS, Martin C, Gao S, Yeung SJ, Liu W, Elting L. A cost-effectiveness analysis of the use of bolus, continuous and dexrazoxane-associated infusion of doxorubicin in breast cancer in the reduction of cardiomyopathy related morbidity and mortality. The Proceedings of the 2001 Annual meeting of the American Society of Clinical Oncology:Abstract 962, 2001. e-Pub 2001.
Book Chapters
- Gao, S, Shannon V. Vascular Emergencies. In: Oncologic Emergencies. B.C. Decker Inc, 2002.
- Escalante C, Hwang J, Grover T, Rajagopal A, Deng G, Lazo-Diaz G, Forman A, Manzullo E, Gao S. Major Presenting Symptoms. In: Oncologic Emergencies. 1st. B.C. Decker, 25-60, 2002.
Patient Reviews
CV information above last modified March 26, 2026